Rep. Julia Letlow (R-La.) has disclosed the sale of Bristol-Myers Squibb Company (BMY) common stock, according to a Periodic Transaction Report filed with the U.S. House of Representatives. The transaction was executed by the member of Congress herself on April 28, 2025, with the disclosed value falling between $1,001 and $15,000.
The sale was made through a Merrill Lynch Investment Account, identified in the filing as Account #025, one of several brokerage accounts Letlow has used to hold and trade individual securities. Bristol-Myers Squibb, a major pharmaceutical company, is a stock that has previously appeared in Letlow’s disclosed portfolio activity.
A Late Filing
The STOCK Act requires members of Congress to publicly disclose securities transactions within 45 days of the trade date. In this case, the report was filed 105 days after the April 28 transaction date, well past that statutory window. The filing does not include an explanation for the delay, and whoisbuyingnow.com is not speculating as to the cause. Late filings under the STOCK Act are not uncommon and are treated administratively rather than as evidence of any wrongdoing.
This is not the first time a BMY transaction tied to Letlow’s name has drawn attention for its filing timeline. Our earlier coverage detailed a purchase of Bristol-Myers Squibb shares that was filed 292 days after the transaction date, an even longer gap than the one disclosed here. Taken together, the two filings show a pattern of delayed disclosure around this particular holding, though each report stands as its own separate transaction under the law.
Periodic Transaction Reports like this one are part of the public record maintained to give voters and market watchers visibility into the personal securities activity of lawmakers who have access to non-public briefings, legislative deliberations, and regulatory information relevant to publicly traded companies. Pharmaceutical and healthcare stocks in particular draw scrutiny given Congress’s role in drug pricing policy and health legislation, though no such connection is asserted here.
Readers interested in how institutional money managers are positioning around similar holdings can also review our tracking of large asset managers, such as our page following Capital World Investors’ quarterly 13F portfolio moves, for a broader view of how different classes of investors approach the same sectors.
Whoisbuyingnow.com will continue monitoring future disclosures from Rep. Letlow and other members of Congress as they are filed with the House and Senate.